{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:45:36Z","timestamp":1790401536915,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Natural killer T (NKT) -cells activated with the glycolipid ligand \u03b1-galactosylceramide (\u03b1-GalCer) stimulate a wide array of immune responses with many promising immunotherapeutic applications, including the enhancement of vaccines against infectious diseases and cancer. In the current study, we evaluated whether \u03b1-GalCer generates protective immunity against a swine influenza (SI) virus infection when applied as an intramuscular vaccine adjuvant. Immunization of newly weaned piglets with UV-killed pandemic H1N1 A\/California\/04\/2009 (kCA04) SI virus and \u03b1-GalCer induced high titers of anti-hemagglutinin antibodies and generated virus-specific T cells that localized in intrapulmonary airways and in alveolar walls. Vaccination with \u03b1-GalCer resulted in a systemic increase in NKT-cell concentrations, including in the respiratory tract, which was associated with complete inhibition of viral replication in the upper and lower respiratory tract and much reduced viral shedding. These results indicate that NKT-cell agonists could be used to improve swine vaccine formulations in order to reduce the clinical signs of SI infection and limit the spread of influenza viruses amongst commercial pigs.<\/jats:p>","DOI":"10.1038\/srep23593","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T10:10:25Z","timestamp":1458727825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["\u03b1-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant"],"prefix":"10.1038","volume":"6","author":[{"given":"Bianca L.","family":"Artiaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Hackmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen A.","family":"Richt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Salek-Ardakani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Castleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Lednicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"key":"BFsrep23593_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/zph.12049","volume":"61","author":"A Vincent","year":"2014","unstructured":"Vincent, A. et al. Review of influenza A virus in swine worldwide: a call for increased surveillance and research. Zoonoses Public Hlth. 61, 4\u201317 (2014).","journal-title":"Zoonoses Public Hlth."},{"key":"BFsrep23593_CR2","unstructured":"Brown, G. B. & McMillen, J. K. MaxiVac-Flu: evaluation ofthe safety and efficacy of a swine influenza. in Proceedings of the American Association of Swine Practitioners, 25th Annual Meeting, Chicago, IL 25, 37\u201339 (1994)."},{"key":"BFsrep23593_CR3","first-page":"312","volume":"60","author":"MH Bikour","year":"1996","unstructured":"Bikour, M. H., Cornaglia, E. & Elazhary, Y. Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs. Can. J. Vet. Res. 60, 312\u2013314 (1996).","journal-title":"Can. J. Vet. Res."},{"key":"BFsrep23593_CR4","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1128\/JVI.01038-13","volume":"87","author":"CL Loving","year":"2013","unstructured":"Loving, C. L. et al. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011\u20132012 H3N2v. J. Virol. 87, 9895\u20139903 (2013).","journal-title":"J. Virol."},{"key":"BFsrep23593_CR5","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.vaccine.2010.01.049","volume":"28","author":"AL Vincent","year":"2010","unstructured":"Vincent, A. L. et al. Efficacy of inactivated swine influenza virus vaccines against the 2009 A\/H1N1 influenza virus in pigs. Vaccine 28, 2782\u20132787 (2010).","journal-title":"Vaccine"},{"key":"BFsrep23593_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.coi.2008.03.018","volume":"20","author":"JL Matsuda","year":"2008","unstructured":"Matsuda, J. L., Mallevaey, T., Scott-Browne, J. & Gapin, L. CD1d-restricted iNKT cells, the \u2018Swiss-Army knife\u2019 of the immune system. Curr. Opin. Immunol. 20, 358\u2013368 (2008).","journal-title":"Curr. Opin. Immunol."},{"key":"BFsrep23593_CR7","doi-asserted-by":"publisher","first-page":"11287","DOI":"10.1073\/pnas.0801631105","volume":"105","author":"JM Coquet","year":"2008","unstructured":"Coquet, J. M. et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc. Natl. Acad. Sci. USA 105, 11287\u201311292 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep23593_CR8","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1073\/pnas.0604812103","volume":"103","author":"S Fujii","year":"2006","unstructured":"Fujii, S. et al. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc. Natl. Acad. Sci. USA 103, 11252\u201311257 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep23593_CR9","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.4049\/jimmunol.163.9.4647","volume":"163","author":"C Carnaud","year":"1999","unstructured":"Carnaud, C. et al. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647\u20134650 (1999).","journal-title":"J. Immunol."},{"key":"BFsrep23593_CR10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E","volume":"30","author":"G Eberl","year":"2000","unstructured":"Eberl, G. & MacDonald, H. R. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30, 985\u2013992 (2000).","journal-title":"Eur. J. Immunol."},{"key":"BFsrep23593_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00441-010-1023-3","volume":"343","author":"L Van Kaer","year":"2011","unstructured":"Van Kaer, L., Parekh, V. V. & Wu, L. Invariant natural killer T cells: bridging innate and adaptive immunity. Cell. Tissue. Res. 343, 43\u201355 (2011).","journal-title":"Cell. Tissue. Res."},{"key":"BFsrep23593_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1084\/jem.20021616","volume":"197","author":"G Galli","year":"2003","unstructured":"Galli, G. et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197, 1051\u20131057 (2003).","journal-title":"J. Exp. Med."},{"key":"BFsrep23593_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1189\/jlb.0410191","volume":"88","author":"RR Kulkarni","year":"2010","unstructured":"Kulkarni, R. R., Haeryfar, S. M. & Sharif, S. The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity? J. Leukoc. Biol. 88, 635\u2013643 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"BFsrep23593_CR14","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1172\/JCI36264","volume":"118","author":"C De Santo","year":"2008","unstructured":"De Santo, C. et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 118, 4036\u20134048 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFsrep23593_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1189\/jlb.0411184","volume":"91","author":"WL Kok","year":"2012","unstructured":"Kok, W. L. et al. Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J. Leukoc. Biol. 91, 357\u2013368 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"BFsrep23593_CR16","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1074\/jbc.M111.304758","volume":"287","author":"C Paget","year":"2012","unstructured":"Paget, C. et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287, 8816\u20138829 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFsrep23593_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.virol.2010.08.030","volume":"407","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa, H. et al. IFN-\u03b3 production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells. Virology 407, 325\u2013332 (2010).","journal-title":"Virology"},{"key":"BFsrep23593_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/imt.13.175","volume":"6","author":"LJ Carre\u00f1o","year":"2014","unstructured":"Carre\u00f1o, L. J., Kharkwal, S. S. & Porcelli, S. A. Optimizing NKT cell ligands as vaccine adjuvants. Immunotherapy 6, 309\u2013320 (2014).","journal-title":"Immunotherapy"},{"key":"BFsrep23593_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2217\/imt.10.85","volume":"3","author":"L Van Kaer","year":"2011","unstructured":"Van Kaer, L., Parekh, V. V. & Wu, L. Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens. Immunotherapy 3, 59\u201375 (2011).","journal-title":"Immunotherapy"},{"key":"BFsrep23593_CR20","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.4049\/jimmunol.175.5.3309","volume":"175","author":"SY Ko","year":"2005","unstructured":"Ko, S. Y. et al. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J. Immunol. 175, 3309\u20133317 (2005).","journal-title":"J. Immunol."},{"key":"BFsrep23593_CR21","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1016\/j.vaccine.2009.03.090","volume":"27","author":"SA Kopecky-Bromberg","year":"2009","unstructured":"Kopecky-Bromberg, S. A. et al. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 27, 3766\u20133774 (2009).","journal-title":"Vaccine"},{"key":"BFsrep23593_CR22","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1073\/pnas.0813309106","volume":"106","author":"C Guillonneau","year":"2009","unstructured":"Guillonneau, C. et al. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc. Natl. Acad. Sci. USA 106, 3330\u20133335 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep23593_CR23","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1016\/j.vaccine.2007.04.081","volume":"25","author":"HJ Youn","year":"2007","unstructured":"Youn, H. J. et al. A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine 25, 5189\u20135198 (2007).","journal-title":"Vaccine"},{"key":"BFsrep23593_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/mi.2008.2","volume":"1","author":"H Kamijuku","year":"2008","unstructured":"Kamijuku, H. et al. Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol. 1, 208\u2013218 (2008).","journal-title":"Mucosal Immunol."},{"key":"BFsrep23593_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetimm.2014.09.006","volume":"162","author":"BL Artiaga","year":"2014","unstructured":"Artiaga, B. L., Whitener, R. L., Staples, C. R. & Driver, J. P. Adjuvant effects of therapeutic glycolipids administered to a cohort of NKT cell-diverse pigs. Vet. Immunol. Immunopathol. 162, 1\u201313 (2014).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"BFsrep23593_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1084\/jem.20011786","volume":"195","author":"JE Gumperz","year":"2002","unstructured":"Gumperz, J. E., Miyake, S., Yamamura, T. & Brenner, M. B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625\u2013636 (2002).","journal-title":"J. Exp. Med."},{"key":"BFsrep23593_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20011908","volume":"195","author":"PT Lee","year":"2002","unstructured":"Lee, P. T., Benlagha, K., Teyton, L. & Bendelac, A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195, 637\u2013641 (2002).","journal-title":"J. Exp. Med."},{"key":"BFsrep23593_CR28","doi-asserted-by":"publisher","first-page":"e1001255","DOI":"10.1371\/journal.pbio.1001255","volume":"10","author":"H Watarai","year":"2012","unstructured":"Watarai, H. et al. Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol. 10, e1001255 (2012).","journal-title":"PLoS Biol."},{"key":"BFsrep23593_CR29","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1073\/pnas.0700191104","volume":"104","author":"G Galli","year":"2007","unstructured":"Galli, G. et al. Invariant NKT cells sustain specific B cell responses and memory. Proc. Natl. Acad. Sci. USA 104, 3984\u20133989 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep23593_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1365-2567.2006.02413.x","volume":"119","author":"GA Lang","year":"2006","unstructured":"Lang, G. A., Exley, M. A. & Lang, M. L. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 119, 116\u2013125 (2006).","journal-title":"Immunology"},{"key":"BFsrep23593_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","volume":"12","author":"MT Osterholm","year":"2012","unstructured":"Osterholm, M. T., Kelley, N. S., Sommer, A. & Belongia, E. A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet. Infect. Dis. 12, 36\u201344 (2012).","journal-title":"Lancet. Infect. Dis."},{"key":"BFsrep23593_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nri2451","volume":"9","author":"V Cerundolo","year":"2009","unstructured":"Cerundolo, V., Silk, J. D., Masri, S. H. & Salio, M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9, 28\u201338 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFsrep23593_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.meegid.2010.12.001","volume":"11","author":"J Hass","year":"2011","unstructured":"Hass, J., Matuszewski, S., Cieslik, D. & Haase, M. The role of swine as \u201cmixing vessel\u201d for interspecies transmission of the influenza A subtype H1N1: a simultaneous Bayesian inference of phylogeny and ancestral hosts. Infect. Genet. Evol. 11, 437\u2013441 (2011).","journal-title":"Infect. Genet. Evol."},{"key":"BFsrep23593_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/imm.12247","volume":"142","author":"V Kumar","year":"2014","unstructured":"Kumar, V. & Delovitch, T. L. Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology 142, 321\u2013336 (2014).","journal-title":"Immunology"},{"key":"BFsrep23593_CR35","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.4049\/jimmunol.177.5.2939","volume":"177","author":"YG Chen","year":"2006","unstructured":"Chen, Y. G. et al. CD38 is required for the peripheral survival of immunotolerogenic CD4+ invariant NK T cells in nonobese diabetic mice. J. Immunol. 177, 2939\u20132947 (2006).","journal-title":"J. Immunol."},{"key":"BFsrep23593_CR36","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.4049\/jimmunol.171.3.1266","volume":"171","author":"T Nakamura","year":"2003","unstructured":"Nakamura, T. et al. CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J. Immunol. 171, 1266\u20131271 (2003).","journal-title":"J. Immunol."},{"key":"BFsrep23593_CR37","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4049\/jimmunol.173.2.1043","volume":"173","author":"K Roelofs-Haarhuis","year":"2004","unstructured":"Roelofs-Haarhuis, K., Wu, X. & Gleichmann, E. Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173, 1043\u20131050 (2004).","journal-title":"J. Immunol."},{"key":"BFsrep23593_CR38","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1099\/vir.0.040535-0","volume":"93","author":"W Ma","year":"2012","unstructured":"Ma, W. et al. The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigs. J. Gen. Virol. 93, 1261\u20131268 (2012).","journal-title":"J. Gen. Virol."},{"key":"BFsrep23593_CR39","unstructured":"Lednicky, J. A. & Wyatt, D. E. In Biomedical Tissue Culture (eds Ceccherini-Nell, L. & Matteoli, B. ) 151\u2013178 (InTech, 2012)."},{"key":"BFsrep23593_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1743-422X-7-231","volume":"7","author":"JA Lednicky","year":"2010","unstructured":"Lednicky, J. A. et al. Ferrets develop fatal influenza after inhaling small particle aerosols of highly pathogenic avian influenza virus A\/Vietnam\/1203\/2004 (H5N1). Virol. J. 7, 231 (2010).","journal-title":"Virol. J."},{"key":"BFsrep23593_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1743-422X-8-66","volume":"8","author":"SB Hamilton","year":"2011","unstructured":"Hamilton, S. B. et al. Higher titers of some H5N1 and recent human H1N1 and H3N2 influenza viruses in Mv1 Lu vs. MDCK cells. Virol. J. 8, 66 (2011).","journal-title":"Virol. J."},{"key":"BFsrep23593_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method for estimating fifty percent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"BFsrep23593_CR43","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00335-015-9564-0","volume":"26","author":"G Yang","year":"2015","unstructured":"Yang, G. et al. Targeted disruption of CD1d prevents NKT cell development in pigs. Mamm. Genome 26, 264\u2013270 (2015).","journal-title":"Mamm. Genome"},{"key":"BFsrep23593_CR44","unstructured":"World Health Organization. Manual on animal influenza diagnosis and surveillance. Available at: http:\/\/www.who.int\/immunization\/research\/en\/. (Accessed: 16th February 2016)."},{"key":"BFsrep23593_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cmpb.2010.11.002","volume":"102","author":"AC Elliott","year":"2011","unstructured":"Elliott, A. C. & Hynan, L. S. A SAS(\u00ae) macro implementation of a multiple comparison post hoc test for a Kruskal-Wallis analysis. Comput. Methods Programs Biomed. 102, 75\u201380 (2011).","journal-title":"Comput. Methods Programs Biomed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep23593.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep23593","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep23593.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:36:11Z","timestamp":1672889771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep23593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,15]]}},"alternative-id":["BFsrep23593"],"URL":"https:\/\/doi.org\/10.1038\/srep23593","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,23]]},"assertion":[{"value":"7 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23593"}}